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ABSTRACT 
The purpose of the present study was to prepare and evaluate Itraconazole loaded microsponges using Eudragit for the controlled release of 
the drug and study the effect of stirring rate on the formation of microsponges. Microsponges containing Itraconazole were prepared by using 
quasi-emulsion solvent diffusion method at different stirring rate i.e. 500, 800, 1000, 1200 and 1500rpm.  Particle size of prepared microsponge 
was observed in the range of 78.43 to 23.18 µm. Scanning electron microscopy revealed the porous, spherical nature of the microsponges. The 
production yield, entrapment efficiency, and drug content were found to be 80.88%, 84.53% and 82.89%. The formulation with higher drug to 
polymer ratio 1:10 (i.e. F5) was chosen to investigate the effect of stirring rate on the morphology of microsponges. As the speed was increased, 
the particle size of microsponges was reduced and uniform spherical microsponges were formed. As drug polymer ratio increased, Production 
yield, drug content and entrapment efficiency was found to be increased while drug: polymer ratio has reverse effect on particle size, as drug: 
polymer ratio increase, particle size decreases. The cumulative percentage drug release upto 8hrs for F5 was 89.54% and the mechanism of 
drug release from the formulations during the dissolution was determined using the zero order, first order, higuchi equation and Peppas 
equation. All formulations were best fitted to Zero order and peppas plot. The best formulation F5 follows Zero order release.  
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INTRODUCTION 
A microsponge delivery system (MDS) is highly cross- linked 
porous, polymeric microspheres that can entrap wide range 
of active agents and in response to trigger or stimuli and 
release them onto the skin over a time 1. It is a unique and 
effective technology for the controlled release of topical 
agents. It consists of micro-porous beads, typically 5-300µm 
in diameter that acquire the flexibility to entrap a wide 
variety of active ingredients such as fragrances, sunscreens, 
emollients, anti-fungal, anti-infective, and anti-inflammatory 
agents etc., that are mostly used to prolong the topical 
administration of the drug 2,3. Recently it was investigated 
that microsponges also used for oral drug delivery system. 
Microsponge system has shown to increase the rate of 
solubilisation of poorly water soluble drugs by entrapping 
drugs in the microsponge system’s pores 4. The topical agent 
formulation with microsponge delivery system can be 
prepared in many different forms, such as cream, gel, or 
lotion. When the formulation is applied to the skin, the MDS 
releases its active ingredients on a time and in response to 
other stimuli (rubbing, temperature, pH etc.). They reduce 
side effects, enhance stability and modify drug release. 
Because of the size of the microsponges they cannot pass 
through the stratum corneum, so they remain on the skin 
surface and slowly releasing the active ingredients over a 
period. Slow rate of release from MDS reduce the irritancy 
associated with the topical agents. Slow and gradual release 
pattern of MDS prevents excessive build-up of the active 
agents in the epidermis and dermis. Therefore, these 
particles, remains on the surface of the skin and its fine lines 
delivering the active over prolonged time 5, 6.  
Itraconazole is a trizole antifungal agent used to treat both 
superficial and systemic fungal infections. Itraconazole 
undergo first pass metabolism when taken orally. The 
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purpose of the present study was to prepare and evaluate 
Itraconazole loaded microsponges using Eudragit RSPO for 
the controlled release of the drug and study the effect of 
stirring rate on the formation of microsponges 7. 
MATERIALS AND METHOD 
Materials: Itraconazole gift sample obtained from Haustus 
Biotech. Pvt. Ltd., Tahliwal (Una), dibutylphthalate was 
procured from SD fine chem. Ltd., Mumbai, Polyvinyl alcohol 
was procured  from GlaxoSmithKline pharmaceuticals Ltd. 
Mumbai, Dichloromethane procured from RFCL limited 
Gujarat, India, Ethanol and KBr was procured from Central 
drug house Pvt. Ltd., New Delhi and Distilled water.  
Method of preparation of Itraconazole Microsponges: 
Itraconazole Microsponges were prepared by quasi-emulsion 
solvent diffusion method. To prepare the internal phase, 
Itraconazole was  dissolved  in  20  ml  of  dichloromethane:  
ethanol  (1:1) mixture  to  dissolve  both  the  drug  and  the  
polymer (Eudragit RSPO)  and  to  this  add 0.5 ml of  Dibutyl 
phthalate as a plasticizer. The external phase containing 
100mg of  PVA in water and  was  placed  in  the  vessel  with  
propeller  stirrer rotating  at  different  rpm according to 
batch ,  to  this  add  slowly  internal  phase.  The system was 
thermally controlled at 25° C in a water bath. Agitations up to 
30 min permit the formation of microsponges and continue 
stirring for 8h to get desired rigid microsponges. After 8h 
stop  stirring  filter  the  rigid micro sponges  through  the  
filter  paper  (Whatmann  filter paper  0.45  µm),  washed  
with  distilled  water  and  dried  at  room  temperature [8]. 
Itraconazole microsponges were prepared using various 
drugs: polymer ratios i.e.  1:2, 1:4, 1:6, 1:8 and 1:10 at  
different stirring rate of 500,800,1000,1200 and 1500rpm. 
Five formulation batches were formed from F1 to F5. The 
formulations of various microsponges are shown in table no. 
1.
 
 Table 1: Formulations of Itraconazole Microsponges by Quasi- Emulsion Solvent Diffusion Method 
Formul-
ation 
Drug: 
Polymer 
ratio 
Drug 
(mg) 
Eudragit 
RSPO 
(mg) 
Ethanol+Dichloro-
methane 
(ml) 
Polyvinl 
alcohol 
(mg) 
Distilled 
Water 
(ml) 
Di-butyl 
Phthalate  
(ml) 
Stirring 
rate 
(RPM) 
F1 1:2 100 200 20 100 150 0.5 500 
F2 1:4 100 400 20 100 150 0.5 800 
F3 1:6 100 600 20 100 150 0.5 1000 
F4 1:8 100 800 20 100 150 0.5 1200 
F5 1:10 100 1000 20 100 150 0.5 1500 
 
Standard curve of Itraconazole and absorption maxima  
A precise, sensitive and accurate method for estimating 
Itraconazole was developed using UV visible 
spectrophotometer.  
Preparation of standard stock solution 
Accurately weigh 100 mg Itraconazole was taken in a clean 
and dry 100ml volumetric flask and was dissolved in 7.4 
phosphate buffer. Then 1 ml of above solution was taken and 
then dissolve in another 100ml of 7.4 phosphate buffer ( 
stock solution) than from the stock solution 1ml of solution 
was taken and dissolve in 100ml of 7.4 phosphate buffer to 
make 1μg/ml solution. After that 1,2,3,4,5,6,7,8,9,10μg/ml 
solutions were made by dissolving1,2,3,4,5,6,7,8,9,10μg/ml 
solutions in 10 ml 7.4 phosphate buffer. 
Procedure:  
From stock solution 1,2,3,4,5,6,7,8,9,10ml were withdrawn 
separately in different 10ml volumetric flasks and volume 
made in each case up-to 10ml of 7.4 phosphate buffer to 
produce the concentration 1,2,3,4,5,6,7,8,9,10μg/ml. 
Absorbance of these solutions were recorded at λmax 261nm 
against (distilled water) blank using UV-visible 
spectrophotometer and standard curve was plotted between 
concentration v/s absorbance.  
Preparation of pH 7.4 Phosphate Buffer: Placed 50ml of 
0.2M potassium dihydrogen phosphate in 200ml volumetric 
flask, added the specified volume of 39.1ml of 0.2M sodium 
hydroxide and then added water to make up the volume. 
0.2M Potassium dihydrogen phosphate: Dissolved 
27.218gm of potassium dihydrogen phosphate in 
distilledwater and diluted with distilled water to 1000ml.  
0.2M sodium hydroxide solution: Dissolved 8gm of sodium 
hydroxide in distilled water and diluted with distilled water 
to 1000ml.  
Characterisation of Microsponges: 
Average Particle size of Microsponges:  
Particle size of all the prepared batches of microsponge was 
determined using optical microscopy at 10x and 40x. The 
microsponges were placed on glass slide and observed under 
optical microsponge. The size of 50-100 microsponges was 
measured using optical microscope 7, 8. 
Production/ Percentage yield:  
 The dried microsponges of each batch are weight separately 
and percentage yield is calculated 9 by using following 
equation:- 
Percentage yield 
               
                               
      
 Entrapment efficiency (EE)/ Loading efficiency and 
Actual Drug Content: 
 100 mg of microsponges were accurately weighted. They 
were powdered and extracted with 100 ml of methanol. 
Further it was serially diluted with pH 7.4 phosphate buffer. 
The resulting solution was analysed for Itraconazole drug 
content by measuring absorbance in a UV 
spectrophotometer at 261nm using pH 7.4 phosphate buffer 
as blank. The studies were carried out in triplicate 9. The 
actual drug content and Encapsulation efficacy were 
calculated as given below:  
 Actual drug content(%)=(Mact/Mms)*100 
 Entrapment efficiency(%)=Mact/Mthe)*100 
Where, Mact = actual amount of Itraconazole in weighed 
quantity of microsponges 
 Mms = the weighed quantity of microsponge 
 Mthe = the theoretical amount of Itraconazole in 
microsponges. 
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 Scanning electron microscopy: 
Scanning electron microscopy (SEM) is an electron optical 
imaging technique that provides photographic images and 
elemental information about prepared microsponges. SEM is 
useful for characterizing the morphology and size of 
microscopic specimens with particle size as low as nano 
meter to deca meter, the sample is placed in an evacuated 
chamber and scanned by an electron beam in a controlled 
pattern.  When the electron beam interact with the specimen 
produces a variety of physical phenomena that when 
detected are used to form images and provide elemental 
information about the specimens. Microsponge were fixed on 
aluminium studs and coated with gold using a sputter coater 
SC 502, under vacuum [0.1 mm Hg] 10. The microsponge 
were then analysed by scanning electron microscopy (SEM).  
 In vitro dissolution studies: 
 The release of Itraconazole from microponge was 
investigated in pH 7.4 phosphate buffer as dissolution 
medium (900ml) using USPXXII type I basket apparatus. A 
sample of microsponge equivalent to 100mg of Itraconazole 
was taken in the basket. A speed of 52 rpm and temperature 
of 37±0.5 °c was maintained throughout the experiment. At 
fixed intervals, aliquots (5ml) were withdrawn and replaced 
with fresh dissolution media. The concentration of drug 
released at different time intervals was then determined by 
measuring the absorbance using Double beam UV 
spectrophotometer at 261 nm against blank. The studies 
were carried out in triplicate 11, 12.   
 Kinetic Modeling: 
Data obtained from in-vitro release studied was evaluated to 
check the goodness of fit to various kinetics equations for 
quantifying the phenomena controlling the release from 
microspheres. The kinetic models used were zero order, first 
order, and Higuchi and Korsemeyer - Peppas model 13, 14, 15. 
The goodness of fit was evaluated using the correlation 
coefficient value (R2). 
The results of in-vitro release profile obtained for all the 
formulations were plotted in kinetic models as follows, 
1. cumulative of drug released versus time (zero order 
kinetic models). 
2. Log cumulative percent drug remaining to be absorbed 
versus time (First order model) 
3. Cumulative amount of drug release versus square root of 
time (Higuchi model) 
4. Log cumulative drug release versus log time (Korsemeyer 
– Peppas model) 
Zero Order Kinetics:  
It describes the system in which the rate of drug release is 
independent of its concentration. 
Qt=Qo+Kot 
Where 
Qt=Amount of drug dissolved in time t 
Qos= Initial amount of drug in the solution, which is often 
zero and 
Ko= zero order release constant. 
If the zero order drug release kinetic is obeyed, then a plot of 
Qt versus t will give a 
Straight line with a slope of Ko and an intercept at zero. 
First Order Kinetics 
It describes the rate of drug release from the systems is 
concentration dependent. 
Log Qt=log Qo+kt/2.303 
Where 
Qt=amount of drug released in time t. 
Qo=initial amount of drug in the solution 
k=first order release constant 
If the first order drug release kinetic is obeyed, then a plot of 
log (Qo-Qt) versus t will be 
Straight line. 
With a slope of kt/2.303 and an intercept at t=0 of log Qo 
Higuchi Model 
It describes that the fraction of drug release from a matrix is 
proportional to square root of time. 
Mt/M∞=kt½  
Where  
Mt and M∞ = cumulative amounts of drug release at time t and 
infinite time, 
 k = Higuchi dissolution constant reflection formulation 
characteristics. If the Higuchi model of drug release (i.e. 
Fickian diffusion) is obeyed, then a plot of Mt / M∞ versus t1/2 
will be straight line with slope of k. 
Korsemeyer- Peppas model (Power Law) 
The Korsemeyer- Peppas model describes the drug release 
from the polymeric system in which release deviates from 
Fickian diffusion, as expressed in following equation. 
Mt / M∞=ktn 
Log [Mt/ = M∞] logk + n log t 
Where Mt and M∞ are cumulative amounts of drug release at 
time t and infinite time (i.e. fraction of drug release at time t), 
k =constant incorporating structural and geometrical 
characteristics of CR device, 
n = diffusion release exponent indicative of the mechanism of 
release for drug Dissolution. 
To characterize the release mechanism, 
The dissolution data {Mt/ M∞<0.6} versus log t will be linear 
with slope of n and intercept gives the value of log k. Antilog 
of log k gives the value of k. 
Table 2: Interpretation of diffusion release mechanisms 
n value Mechanism 
  0.45 Fickian diffusion 
0.45 < n< 0.89 Anomalous ( Non- Fickian) diffusion 
   0.89 Case II transport 
  Above 0.89 Super case II  transport 
 
Effect of Formulation Variables on Physical Properties of 
Microsponge: 
Effect of Drug: Polymer ratio:  
In order to evaluate the effect of drug on the formation of 
microsponge, different Eudragit polymer to Itraconazole 
ratios (1:2, 1:4, 1:6, 1:8 and 1:10) were used to prepare 
microsponges. The formed microsponges were evaluated for 
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their appearance, drug content, particle size and entrapment 
efficiency 16.  
Effect of stirring speed on the formation of 
Microsponges: 
In order to evaluate the effect of stirring speed on the 
formation of microsponges, were prepared with different 
RPM of 500, 800, 1000, 1200 and 1500 keeping all the 
variables constant and the formed microsponges were 
evaluated for their drug content and particle size 17,18. 
RESULT AND DISCUSSION 
Determination of absorption maxima ( max)  
UV scan of Itraconazole in phosphate buffer pH 7.4 was done. 
Analysis by UV spectrophotometer depicted absorption 
maxima of Itraconazole at  max was 261nm at pH 7.4 of 
phosphate buffer. 
 
Figure 1: Absorption spectra of Itraconazole 
 
Figure 2: Absorption maxima of Itraconazole 
 Standard curve of Itraconazole in saline phosphate 
buffer (pH 7.4) 
The calibration curve of Itraconazole in phosphate buffer (pH 
7.4). A straight line was obtained by plotting the 
concentration of Itraconazole (µg/ml) versus absorbance. 
The result indicates that the calibration curve of the drug 
obeys Beer's law. 
Table 3: Standard curve data of Itraconazole in 
phosphate buffer (pH 7.4) 
conc. (μg/ml) absorbance 
1 0.012 
2 0.014 
3 0.017 
4 0.02 
5 0.023 
6 0.026 
7 0.029 
8 0.034 
9 0.037 
10 0.057 
 
 
Figure 3: Calibration curve of Itraconazole 
 
Characterization of Microsponges 
 Size analysis of Microsponge: 
The average particle size of Itraconazole Microsponges is 
ranged from 78.43 to 23.18. It was observed that as the ratio 
of drug to polymer and stirring rate increased, the particle 
size decreased.  
Table 4: Average Particle Size of Microsponge 
S .No Formulation code Particle size 
1 F1 78.43 
2 F2 63.16 
3 F3 55.58 
4 F4 46.91 
5 F5 23.18 
  
Drug Content: 
The drug content was determined by using phosphate buffer 
(pH 7.4) with the help of UV spectrophotometer by 
dissolving the formulation in phosphate buffer for 24hrs and 
then sample was taken and analysed in UV- 
spectrophotometer, it was revealed that the drug content 
increased with increase in rotation per minute as well 
increase in the drug: polymer ratio. The drug content from 
F1-F5 ranges between 30.65 -82.89. 
Table 5: Drug Content of Microsponges 
S .No Formulation code % Drug content 
1 F1 30.65 
2 F2 49.55 
3 F3 68.93 
4 F4 74.68 
5 F5 82.89 
mean±SD, n = 3. 
Production/Percentage yield (%) 
 Production yield calculated for all microsponges ranged 
from 35.30 to 80.88 %. It was found that production yield 
was greatly affected by drug: polymer ratio. It was indicated 
that increasing polymer concentration, increased production 
yield. The readings are mean of three different 
measurements ±SD. 
Table 6:  Production Yield of Itraconazole Microsponge 
S .No Formulation code Production yield 
1 F1 35.30 
2 F2 49.64 
3 F3 69.27 
4 F4 75.79 
5 F5 80.88 
y = 0.0032x + 0.0076 
R² = 0.9944 
0
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Figure 4: Production Yield of Itraconazole Microsponge 
 Entrapment efficiency/Loading efficiency: 
The Entrapment efficiency of Itraconazole microsponges 
formulations are given in table 5.9 the loading efficiency 
calculated for all microsponges range from 31.23-84.53 % 
the highest loading efficiency. It was found for the 
formulation F5 where a greater amount of drug was 
encapsulated. It is indicated that Itraconazole/ Eudragit 
RSPO ratio (1:10) had the optimum capacity for drug 
entrapment. 
Table 7: Entrapment Efficiency of Itraconazole 
Microsponge 
S .No Formulation code Entrapment 
efficiency±*SD 
1 F1 31.23 
2 F2 50.71 
3 F3 69.13 
4 F4 75.82 
5 F5 84.53 
mean±SD, n = 3. 
 
Figure 5: Entrapment Efficiency of Itraconazole 
Microsponge 
 Scanning electron microscopy  
 The SEM photographs of the microsponges at 1200 and 
1500 rpm are shown in fig.5.8 and 5.9. SEM images showed 
the microsponges are porous and spherical in shape. No 
intact drug crystal is seen visually and inner structure was 
porous with void spaces. The pores were induced by the 
diffusion of the solvent from the surface of the microsponges. 
It was hypothesized that with the increase in speed, the 
precipitation of polymer solution droplets gradually became 
slower, allowing more time for formation of agglomeration. 
Hence for batch F5 desired porous micro sponges with 
maximum entrapment of drug was observed.                          
 
Figure 6: SEM images of drug loaded Microsponges at 
1200 rpm 
 
Figure 7: SEM image of drug loaded Microsponges at 
1500 rpm 
In-vitro Dissolution study: 
The increased concentration of polymer showed the 
increased drug encapsulation efficiency. It was found that 
after 8hrs of dissolution study the formulations F1, F2, F3, F4 
and F5 (figure 7) were showing 50.64, 51.32, 65.49, 82.61   
and 87.54% of drug release in 8 hrs. The study indicated that 
the amount of drug release is increased. Formulation F5 
shows better result with 87.54 (% drug release) than other 
formulations.
 
 
Figure 8: In-Vitro Drug Release Profile of Itraconazole Microsponges 
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Drug Release kinetics of Itraconazole Microsponge: 
The mechanism of drug release from the formulations during the dissolution was determined using the zero order, first order, 
higuchi equation and Peppas equation. 
Zero Order Release Kinetics: 
 
Figure 9: Zero Order drug release profile of Itraconazole Microsponge 
 First Order Release Kinetics: 
 
Figure 10: First Order Drug Release Profile of Itraconazole Microsponge 
 Higuchi Release Kinetics: 
 
Figure 11: Higuchi Release Kinetic Profile of Itraconazole Microsponge 
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 Korsmeyer-Peppas Release Kinetic Data of Itraconazole: 
 
Figure 12: Peppas Release Kinetic Profile of Itraconazole Microsponge 
 Kinetic Modeling of microsponge formulations: 
In vitro drug release data of the microsponge formulations was subjected to goodness of fit test by linear regression analysis 
according to zero order and first order kinetic equations.  
Table 8: Kinetic Modeling of Micro Sponge formulation 
 
 
Formulation 
Zero order 
Kinetic 
data 
First order 
Kinetic         data 
Higuchi 
Matrix 
Kinetic data 
 
Peppas kinetic data 
 
 
Best fit 
Model Regression 
Coefficient(r2) 
Regression 
Coefficient(r2) 
Regression 
Coefficient9(r2) 
Regression 
Coefficient(r2) 
n-value 
F1 0.991 0.995 0.954 0.728 1.309 Zero Order 
F2 0.963 0.978 0.964 0.647 1.243 Zero Order 
F3 0.945 0.973 0.985 0.582 1.236 Zero Order 
F4 0.964 0.925 0.967 0.589 1.300 Zero Order 
F5 0.959 0.875 0.952 0.581 1.302 Zero Order 
 
The mechanism of drug release from the formulations during 
the dissolution was determined using the zero order, first 
order, higuchi equation and Peppas equation. All 
formulations were best fitted to Zero order and peppas plot. 
The best formulation F5 follows Zero order release  
Table 9: Interpretation of diffusion release mechanisms 
n value Mechanism 
0.45 Fickian diffusion 
0.45 < n< 0.89 Anomalous ( Non- Fickian) diffusion 
0.89 Case Ⅱ transport 
Above 0.89 Super case Ⅱ transport 
 
 Effect of Formulation variables on the formation of 
Microsponges: 
 Effect of drug: polymer ratio:  
As the drug polymer ratio increased Production yield, drug 
content and entrapment efficiency was found to be increased 
while drug: polymer ratio has reverse effect on particle size, 
as drug: polymer ratio increase, particle size decreases as 
shown in the table 4.  
 Effect of Stirring rate on the morphology and yield 
of Microsponges: 
The effect of stirring rate on the morphology of 
microsponges is shown in Fig.6 and 7. The formulation with 
higher drug to polymer ratio (i.e F4 and F5) was chosen to 
investigate the effect of stirring rate on the morphology of 
microsponges. The stirring rate was varied in the range of 
500 to 1500 rpm. As the speed was increased the size of 
microsponges was reduced and the microsponges were 
found to be spherical and uniform. It was observed that with 
increased drug: polymer ratio particle size decreased, which 
could be correlated with the kinetics of microsponge 
formation in the presence of comparatively lower 
concentrations of the polymer. It was also noted that at 
higher stirring rate, the production yield was increased. 
 Effect of Polymer concentration: 
As the polymer concentration increased, more amount of 
polymer surrounding the drug, thus increasing the thickness 
of the wall of the polymer matrix which led to extended 
diffusion path and ultimately to lesser drug release or 
extended release. 
CONCLUSION 
The aim of the present study was to make the Itraconazole 
microsponges so that the drug is able to release in a 
controlled manner and also enhance the bioavailability of the 
drug. Itraconazole is a poorly soluble drug and undergo first 
pass metabolism when taken orally, thus selected as a model 
drug for MDDS to overcome these problems. 
The method used for the preparation of Itraconazole 
microsponges was quasi-emulsion solvent diffusion method 
using Eudragit RSPO as a polymer. This method found to be 
simple, reproducible and rapid  
- Compatibility studies were performed for the drug 
(Itraconazole) and polymer (Eudragit RSPO). 
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- FT-IR spectroscopy analyses indicated the chemically 
stable i.e. no interaction between the drug and polymer. 
- Standard graph was drawn for Itraconazole and it was 
found that the study showed linearity (R2 = 0.994) and 
obeyed Beer Lambert’s law. 
-  SEM photographs showed the spherical nature of the 
micro sponges in all variations.  
- The mechanism of drug release from the formulations 
during the dissolution was determined using the zero 
order, first order, higuchi equation and Peppas 
equation. All formulations were best fitted to Zero 
order and Peppas plot. 
- Varied drug–polymer ratio and stirring rate reflected 
remarkable effect on particle size, drug content and 
encapsulation efficiency. It was observed that as the 
drug to polymer ratio was increased, the particle size 
decreased.  
- The effect of stirring rate on the morphology of 
microsponges was also investigated. As the speed was 
increased, the size of microsponges was reduced and 
uniform spherical microsponges were formed .It was 
also noted that at higher stirring rate, the production 
yield was decreased. Possibly at the higher stirring 
rates the polymer adhered to paddle due to the 
turbulence created within the external phase, and 
hence production yield increased. 
- The mechanism of drug release from the formulations 
during the dissolution was determined using the zero 
order, first order, higuchi equation and Peppas 
equation. All formulations were best fitted to Zero 
order and Peppas plot. The best formulation F5 follows 
Zero order release. 
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